Cell size is a fundamental parameter of tissue physiology. It is the building block in shaping tissues, and aberrant cell size is associated with numerous defects in cellular biosynthesis, tissue malformation, and impaired tissue function. Work from unicellular yeast showed that cell size can be controlled by coupling cell growth to progression from G1 to S phase of the cell cycle, so that smaller-born cells spend longer and grow proportionately more in G1 phase compared to larger-born cells. However, the majority of studies of in vitro animal cell lines did not identify size coupled G1/S transition as the mechanism of size control. In my postdoctoral studies, I pioneered a study to address how an in vivo mouse epithelium controls its cell size. In striking contrast to the majority of studies in vitro, I found that epidermal stem cells in vivo control their size by coupling the timing of their G1/S transition to cell size, similar to yeast. Currently, it is unknown how cell size information is imparted to cell cycle signaling network to result in a cell size-dependent G1/S transition rate. Here, I propose to determine the molecular mechanism underlying cell size-dependent G1/S transition through an integrated set of aims.
These aims will test my hypothesis that a cell size-dependent modulation of the retinoblastoma protein (RB) pathway underlies G1/S size control in mammalian tissues. During the training phase of this award, I propose to use quantitative live-cell imaging combined with genetic perturbation to test this hypothesis in two models of mammalian epithelia:
(Aim 1) ex vivo intestinal organoids;
and (Aim 2) the in vivo mouse epidermis. During the independent phase of this award, I propose to (Aim 3) establish an experimental platform to facilitate CRISPR-based endogenous tagging of proteins in intestinal organoids. This will generate live-cell imaging reagents necessary for further characterization of how cell cycle and cell size are coupled, as well as how cell size interacts with other aspects of tissue physiology, including tissue tension and cytoskeletal dynamics. With the help of an outstanding team of mentors, collaborators, and consultants, I will train in cutting-edge live-cell imaging, hone research techniques, and acquire skills for my career development. Together, the proposed scientific and training program form a strong foundation for an independent research career in understanding the role of cell size in tissue morphogenesis and maintenance.

Public Health Relevance

Cell size profoundly impacts cell physiology and tissue shape, but the mechanism by which it is controlled in mammalian tissues is poorly understood. This project will identify the molecular mechanisms controlling cell size by determining how cell growth is coupled to cell cycle transitions in mammalian epithelia. This will further our understanding of cell size maintenance, and yield insight into disease states arising from abnormal tissue morphogenesis and mis- regulation the cell cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Career Transition Award (K99)
Project #
1K99GM138712-01
Application #
10038447
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Janes, Daniel E
Project Start
2020-09-01
Project End
2022-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Stanford University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305